电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

CD235a/GYPA 抗体

There is 1 publication for this product available. The 大鼠 单克隆 anti-CD235a/GYPA antibody is suitable to detect CD235a/GYPA in samples from 人. It has been validated for FACS, IHC (p), IHC (fro) 和 CyTox.
产品编号 ABIN2479385
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for CD235a/GYPA 抗体 (ABIN2479385)

抗原

See all CD235a/GYPA (GYPA) 抗体
CD235a/GYPA (GYPA) (Glycophorin A (GYPA))

适用

  • 172
  • 17
  • 9
  • 2

宿主

  • 100
  • 79
  • 9
  • 1
大鼠

克隆类型

  • 120
  • 68
单克隆

标记

  • 65
  • 20
  • 14
  • 10
  • 7
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This CD235a/GYPA antibody is un-conjugated

应用范围

  • 106
  • 84
  • 68
  • 34
  • 26
  • 24
  • 20
  • 18
  • 13
  • 13
  • 12
  • 5
  • 5
  • 5
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro)), Cytotoxicity Test (CyTox)

克隆位点

YTH89-1
  • 产品特性

    Purified IgG

    纯化方法

    Purified

    亚型

    IgG2b
  • 应用备注

    Optimal working dilution should be determined by the investigator.

    限制

    仅限研究用
  • 状态

    Liquid

    浓度

    1 mg/mL
  • Basu, Banerjee, Ghosh, Chakrabarti: "Erythrocyte membrane defects and asymmetry in paroxysmal nocturnal hemoglobinuria and myelodysplastic syndrome." in: Hematology (Amsterdam, Netherlands), Vol. 15, Issue 4, pp. 236-9, (2010) (PubMed).

  • 抗原

    CD235a/GYPA (GYPA) (Glycophorin A (GYPA))

    别名

    CD235a

    背景

    Synonyms: GLYCOPHORIN A

    基因ID

    2993

    UniProt

    P02724

    途径

    Maintenance of Protein Location
You are here: